Abstract

Scalp tumors are among the most commonly encountered tumors. Behaviour and management of scalp tumors depends heavily on cell lineage. Appropriate identification of these tumors is paramount in mitigating disease burden. Most tumors require surgical resection at a minimum; others will require adjuvant therapies.

• 1.   Persing JS, Persing SM, Clune JE, Persing JA. Scalp tumors. In: Winn HR, editor. Youmans and Winn neurological surgery. 7th ed. Philadelphia: Elsevier; 2017.
• 2.   Lee JH, Ahn SJ, Kim HJ, Jang SE, Noh GY, Kim HR. Cutaneous metastasis from lung cancer: a single-institution retrospective analysis. Tuberc Respir Dis. 2011;70(2):139–42.
• 3.   Song Z, Lin B, Shao L, Zhang Y. Cutaneous metastasis as an initial presentation in advanced non-small cell lung cancer and its poor survival prognosis. J Cancer Res Clin Oncol. 2012;138(10):1613–7.
• 4.   Lookingbill DP, Spangler N, Sexton FM. Skin involvement as the presenting sign of internal carcinoma: a retrospective study of 7316 cancer patients. J Am Acad Dermatol. 1990;22(1):19–26.
• 5.   Mollet TW, Garcia CA, Koester G. Skin metastases from lung cancer. Dermatol Online J. 2009;15(1):1.
• 6.   Molina Garrido MJ, Guillén Ponce C, Soto Martinez JL, Martinez Y, Sevilla C, Carrato Mena A. Cutaneous metastases of lung cancer. Clin Transl Oncol. 2006;8(5):330–3.
• 7.   Hidaka T, Ishii Y, Kitamura S. Clinical features of skin metastasis from lung cancer. Intern Med. 1996;35(6):459–62.
• 8.   Kikuchi Y, Matsuyama A, Nomura K. Zosteriform metastatic skin cancer: report of three cases and review of the literature. Dermatology. 2001;202(4):336–8.
• 9.   Marcoval J, Moreno A, Peyrí J. Cutaneous infiltration by cancer. J Am Acad Dermatol. 2007;57(4):577–80.
• 10.   Perng DW, Chen CH, Lee YC, Perng RP. Cutaneous metastasis of lung cancer: an ominous prognostic sign. Zhonghua Yi Xue Za Zhi (Taipei). 1996;57(5):343–7.
• 11.   Albright AL, Pollack IF, Adelson PD. Principles and practice of pediatric neurosurgery. 3rd ed. New York (NY): Thieme; 2015.
• 12.   Tonsgard JH. Clinical manifestations and management of neurofibromatosis type 1. Semin Pediatr Neurol. 2006;13(1):2–7.
• 13.   Jallo GI, Kothbauer KF, Recinos VMR. Handbook of pediatric neurosurgery. New York (NY): Thieme; 2018.
• 14.   Krohel GB, Rosenberg PN, Wright JE, Smith B. Localized orbital neurofibromas. Am J Ophthalmol. 1985;100(3):458–64.
• 15.   Ardashev VN, Seriakov AP, Nikolaeva SN, Olelevich VG. [Diagnostics of neurofibromatosis (Recklinghausen disease)]. Voen Med Zh. 2004;325(6):41–4.
• 16.   Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44(2):81–8.
• 17.   Prada CE, Rangwala FA, Martin LJ, Lovell AM, Saal HM, Schorry EK, et al. Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1. J Pediatr. 2012;160(3):461–7.
• 18.   Raja AI, Yeaney GA, Jakacki RI, Albright AL. Extraventricular neurocytoma in neurofibromatosis type 1: case report. J Neurosurg Pediatr. 2008;2(1):63–7.
• 19.   Yohay K. Neurofibromatosis type 1 and associated malignancies. Curr Neurol Neurosci Rep. 2009;9(3):247–53.
• 20.   Navarro OM, Laffan EE, Ngan BY. Pediatric soft-tissue tumors and pseudotumors: MR imaging features with pathologic correlation. Radiographics. 2009;29(3):881-906.
• 21.   Weiss LM. Soft tissues. 2nd ed. Philadelphia: Elsevier Inc.; 2009.
• 22.   Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med. 2010;12(1):1–11.
• 23.   Abbas O, Bhawan J. Cutaneous plexiform lesions. J Cutan Pathol. 2010;37(6):613–23.
• 24.   Krathen RA, Orengo IF, Rosen T. Cutaneous metastasis: a meta-analysis of data. South Med J. 2003;96(2):164–7.
• 25.   Fay T, Henry GC. Correlation of body segmental temperature and its relation to the location of carcinomatous metastasis: clinical observations and response to methods of refrigeration. Surg Gynecol Obstet. 1938;66:512–4.
• 26.   Dreizen S, Dhingra HM, Chiuten DF, Umsawasdi T, Valdivieso M. Cutaneous and subcutaneous metastases of lung cancer: clinical characteristics. Postgrad Med. 1986;80(6):111–6.
• 27.   Brownstein MH, Helwig EB. Metastatic tumors of the skin. Cancer. 1972;29(5):1298–307.
• 28.   Chiu CS, Lin CY, Kuo TT, Kuan YZ, Chen MJ, Ho HC. Malignant cutaneous tumors of the scalp: a study of demographic characteristics and histologic distributions of 398 Taiwanese patients. J Am Acad Dermatol. 2007;56(3):448–52.
• 29.   Farley R, Manolidis S, Ratner D. Adenocarcinoma of the lung metastatic to the skull presenting as a scalp cyst. J Am Acad Dermatol. 2006;54(5 Suppl):S248-9.
• 30.   Miyazaki K, Masuko H, Satoh H, Ohtsuka M. Lung cancer with spontaneous regression of scalp metastasis. Respir Med Extra. 2007;3(2):83–5.
• 31.   Khajavi M, Khoshsirat S, Ahangarnazari L, et al. A brief report of plexiform neurofibroma. Curr Probl Cancer. 2018;42(2):256–60.
• 32.   Tchernev G, Chokoeva AA, Patterson JW, et al. Plexiform neurofibroma: a case report. Medicine (Baltimore). 2016;95(6):e2663.
• 33.   Williams VC, Lucas J, Babcock MA, et al. Neurofibromatosis type 1 revisited. Pediatrics. 2009;123(1):124–33.
• 34.   Gross AM, Singh G, Akshintala S, et al. Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1. Neuro Oncol. 2018;20(12):1643–51.
• 35.   Bakshi SS. Plexiform neurofibroma. Cleve Clin J Med. 2016;83(11):792.
• 36.   Polak M, Polak G, Brocheriou C, et al. Solitary neurofibroma of the mandible: case report and review of the literature. J Oral Maxillofac Surg. 1989;47(1):65–8.
• 37.   Evans DG, Howard E, Giblin C, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010;152A(2):327–32.
• 38.   Liu S, Zhou X, Song A, et al. Giant plexiform neurofibroma of thigh in a young woman. Postgrad Med J. 2019;95(1126):459–60.
• 39.   Ruggieri M, Pavone V, Polizzi A, et al. Unusual form of recurrent giant cell granuloma of the mandible and lower extremities in a patient with neurofibromatosis type 1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;87(1):67–72.
• 40.   Sabatini C, Milani D, Menni F, et al. Treatment of neurofibromatosis type 1. Curr Treat Options Neurol. 2015;17(6):355.
• 41.   Kumar S, Bhaskar S, Handa A, et al. Diffuse neurofibroma of scalp. Asian J Neurosurg. 2014;9(4):237.
• 42.   Smith KB, Wang DL, Plotkin SR, et al. Appearance concerns among women with neurofibromatosis: examining sexual/bodily and social self-consciousness. Psychooncology. 2013;22(12):2711–9.
• 43.   Riccardi VM. Von Recklinghausen neurofibromatosis. N Engl J Med. 1981;305(27):1617–27.
• 44.   Friedrich RE, Schmelzle R, Hartmann M, et al. Resection of small plexiform neurofibromas in neurofibromatosis type 1 children. World J Surg Oncol. 2005;3(1):6.
• 45.   Needle MN, Cnaan A, Dattilo J, et al. Prognostic signs in the surgical management of plexiform neurofibroma: the Children’s Hospital of Philadelphia experience, 1974-1994. J Pediatr. 1997;131(5):678–82.
• 46.   Balaji SM. Surgical management of recurrent neurofibroma of infratemporal region: a case report with 20-year follow-up. Indian J Dent Res. 2017;28(6):695–8.
• 47.   Roberts AHN, Crockett DJ. An operation for the treatment of cutaneous neurofibromatosis. Br J Plast Surg. 1985;38(2):292–3.
• 48.   Parsons CM, Canter RJ, Khatri VP. Surgical management of neurofibromatosis. Surg Oncol Clin N Am. 2002;11(1):151-69.

Data Sharing Statement

Funding